Coldrex MaxGrip

País: Armênia

Língua: inglês

Origem: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Ingredientes ativos:

paracetamol, phenylephrine (phenylephrine hydrochloride), ascorbic acid

Disponível em:

SmithKline Beecham S.A. Ctra. de Ajalvir

DCI (Denominação Comum Internacional):

paracetamol, phenylephrine (phenylephrine hydrochloride), ascorbic acid

Dosagem:

1000mg+10mg+40mg

Forma farmacêutica:

powder for oral solution with lemon flavour

Tipo de prescrição:

OTC

Características técnicas

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
ColdrexMaxGrip
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE CONSTITUENTS:
Paracetamol
1000.00 mg
Phenylephrine Hydrochloride
10.00 mg
Ascorbic acid
40.00 mg
3.
PHARMACEUTICAL FORM
Powder for Oral Solution with lemon flavour.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
The short term symptomatic relief of cold & flu symptoms including
headache, sore throat, nasal
congestion, sinusitis and its associated pain, body aches and pains,
and fever.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For oral administration. Empty the contents of the sachet into a
beaker and fill with very hot
water. Stir well. Add cold water as necessary.
Adults (including the elderly) and children aged 12 years and over:
One sachet to be taken every four to six hours as required.
One sachet to be taken every four to
six hours as required.
Maximum daily dose - fore sachets in any 24-hour period.
Minimum dosing interval: 4 hours.
Not recommended for children under the age of 12 years, except on
medical advice.
Maximum duration of use without medical advice: 7 days.
If symptoms persist, consult a doctor.
Do not exceed the stated dose.
The lowest dose necessary to achieve efficacy should be used.
4.3
CONTRAINDICATIONS
This product is contraindicated in following cases:
• Hypersensitivity to paracetamol, phenylephrine, ascorbic acid or
any of the excipients;
• Patiens, who are taking, or have taken, within the last two weeks,
monoamine oxidase
inhibitors, which typically are used to treat depression;
• Pheochromocytoma;
• Closed-angle glaucoma;
• Hepatic or severe renal insufficiency;
• Hypertension;
• Hyperthyroidism;
• Diabetes
• Heart disease
• Patients, taking beta-blockers and tricyclic antidepressants.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Contains
paracetamol.
Do
not
use
with
any
other
paracetamol-containing
products,
decongestants
(medicines
for
the
relief
congestion
or
blocked
nose)
or
cold
and
flu
medicines. The concomitant use with o